L. Thomas
Impact in
- Dermatology top 0.1%
- Cutaneous lymphoproliferative disorders research
- Oncology top 0.2%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 124
- Cutaneous Melanoma Detection and Management 90
- CAR-T cell therapy research 14
-
- Melanoma and MAPK Pathways 36
- Co-authors
- Stéphane Dalle (104 shared papers)B. Balme (78 shared papers)H. Sherwood Lawrence (14 shared papers)John R. David (10 shared papers)Salah Al‐Askari (8 shared papers)Jean‐Jacques Grob (18 shared papers)Claus Garbe (14 shared papers)Michele Maio (11 shared papers)
- Journals
- British Journal of Dermatology (32 papers)Dermatology (24 papers)Journal of the European Academy of Dermatology and Venereology (20 papers)Journal of Clinical Oncology (16 papers)Clinical and Experimental Dermatology (10 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
L. Thomas
377 papers receiving 13.4k citations
L. Thomas's Hit Papers
Peers
Comparison fields: 5 of 192
- Dermatology 1.8k
- Oncology 5.5k
- Immunology 2.1k
- Immunology and Allergy 444
- Epidemiology 2.3k
Countries citing papers authored by L. Thomas
This map shows the geographic impact of L. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Thomas more than expected).
Fields of papers citing papers by L. Thomas
This network shows the impact of papers produced by L. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Thomas. The network helps show where L. Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 400 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma Hit paper breakdown → | 2014 | 1506 |
| 2 | Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study Hit paper breakdown → | 2009 | 939 |
| 3 | Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial Hit paper breakdown → | 2017 | 490 |
| 4 | Delayed Hypersensitivity in vitro. I. The Specificity of Inhibition of Cell Migration by Antigens. Hit paper breakdown → | 1964 | 387 |
| 5 | Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial Hit paper breakdown → | 2015 | 374 |
| 6 | 1992 | 289 | |
| 7 | 1964 | 268 | |
| 8 | 1954 | 242 | |
| 9 | 2019 | 201 | |
| 10 | 2006 | 186 | |
| 11 | 2002 | 176 | |
| 12 | 2007 | 173 | |
| 13 | 2015 | 169 | |
| 14 | 2004 | 158 | |
| 15 | 1998 | 134 | |
| 16 | 1981 | 134 | |
| 17 | Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. | 1991 | 134 |
| 18 | 2011 | 133 | |
| 19 | 1999 | 128 | |
| 20 | 2021 | 121 |
About L. Thomas
L. Thomas is a scholar working on Oncology, Molecular Biology, Dermatology, Epidemiology and Genetics, having authored 400 papers that have together received 14.1k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (90 papers), Melanoma and MAPK Pathways (36 papers), Cutaneous lymphoproliferative disorders research (31 papers), Nail Diseases and Treatments (23 papers), Nonmelanoma Skin Cancer Studies (18 papers), Genetic and rare skin diseases. (16 papers), Immunotherapy and Immune Responses (14 papers) and CAR-T cell therapy research (14 papers). The work is most often cited by research in Dermatology (1.8k citations), Oncology (5.5k citations), Immunology (2.1k citations), Immunology and Allergy (444 citations) and Epidemiology (2.3k citations). L. Thomas has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Stéphane Dalle, B. Balme, H. Sherwood Lawrence, John R. David, Salah Al‐Askari, Jean‐Jacques Grob, Claus Garbe, Michele Maio, Alice Phan and Brigitte Dréno. Their work appears in journals such as British Journal of Dermatology, Dermatology, Journal of the European Academy of Dermatology and Venereology, Journal of Clinical Oncology and Clinical and Experimental Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.